1-16 of 16
Holden T Maecker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Study to Determine the Pathogenesis of Autoimmune Thrombocytopenia in Pediatric Patients

Prachi Sharma, Maritza E. Ruiz, Clara Lo, Holden T Maecker, Loan Hsieh, Diane J. Nugent
Journal: Blood
Blood (2024) 144 (Supplement 1): 3943.
https://doi.org/10.1182/blood-2024-201104
Published: 2024
Journal Articles

Long-Term Efficacy and Immune Reconstitution with Bendamustine As a Lymphodepleting Agent for Axicabtagene Ciloleucel (Axi-Cel) in Patients with Refractory or Relapsed Large B-Cell Lymphoma (LBCL)

Sushma Bharadwaj, Eric Lau, Anmol Goyal, Mark P. Hamilton, Hrishikesh Srinagesh, Alexandria Jensen, Shriya Syal, Jayasindhu Mallampet, Theresa Latchford, Bita Sahaf, Wen-Kai Weng, Melody Smith, Holden T Maecker, Matthew J. Frank, David B. Miklos, Saurabh Dahiya
Journal: Blood
Blood (2023) 142 (Supplement 1): 4878.
https://doi.org/10.1182/blood-2023-188166
Published: 2023
Journal Articles

Platelet Transcriptome Yields Progressive Markers in Chronic Myeloproliferative Neoplasms and Identifies Putative Targets of Therapy

Zhu Shen, Wenfei Du, Cecelia Perkins, Lenn Fechter, Vanita Natu, Holden T. Maecker, Jesse W Rowley, Jason Gotlib, James L Zehnder, Anandi Krishnan
Journal: Blood
Blood (2021) 138 (Supplement 1): 1469.
https://doi.org/10.1182/blood-2021-153323
Published: 2021
Journal Articles

Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia

Caroline Duault, Anil Kumar, Adeleh Taghi Khani, Sung June Lee, Lu Yang, Min Huang, Christian Hurtz, Bryan Manning, Lucy Ghoda, Tinisha McDonald, Norman J. Lacayo, Kathleen M. Sakamoto, Martin Carroll, Sarah K. Tasian, Guido Marcucci, Jianhua Yu, Michael A. Caligiuri, Holden T. Maecker, Srividya Swaminathan
Journal: Blood
Blood (2021) 138 (16): 1465–1480.
https://doi.org/10.1182/blood.2020009871
Published: 2021
Includes: Supplemental data
Journal Articles

Activated Natural Killer Cells Are Associated with Poor Clinical Prognosis in High-Risk B- and T- Cell Acute Lymphoblastic Leukemia

Caroline Duault, PharmD, PhD, Anil Kumar, PhD, Adeleh Taghi Khani, PhD, Sung June Lee, BA, Lu Yang, PhD, Min Huang, PhD, Christian Hurtz, PhD, Bryan Manning, BS, Lucy Ghoda, PhD, Tinisha McDonald, BS, Norman J. Lacayo, MD, Kathleen M. Sakamoto, MD PhD, Martin P. Carroll, MD, Guido Marcucci, MD, Jianhua Yu, PhD, Michael A. Caligiuri, MD, Holden T. Maecker, PhD, Srividya Swaminathan, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39.
https://doi.org/10.1182/blood-2020-140044
Published: 2020
Journal Articles

High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunity

Tom Erkers, Bryan J. Xie, Laura J. Kenyon, Brian Smith, Mary Rieck, Kent P. Jensen, Xuhuai Ji, Marina Basina, Samuel Strober, Robert S. Negrin, Holden T. Maecker, Everett H. Meyer
Journal: Blood
Blood (2020) 135 (11): 814–825.
https://doi.org/10.1182/blood.2019001903
Published: 2020
Includes: Supplemental data
Journal Articles

MYC Oncogene Abrogates Natural Killer (NK) Cell-Mediated Immune Surveillance of B- and T- Lymphoid Malignancies By Suppressing STAT1/2-Type I IFN Signaling

Srividya Swaminathan, PhD, Line Dam Heftdal, MD, Daniel Liefwalker, PhD, Renumathy Dhanasekaran, MD, Anja Deutzmann, PhD, Crista Horton, BS, Adriane Mosley, BS, Mariola Liebersbach, BS, Andrew Gentles, PhD, Holden T. Maecker, PhD, Dean Felsher, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 730.
https://doi.org/10.1182/blood-2019-122607
Published: 2019
Journal Articles

MYC Functions As a Master Switch for Natural Killer Cell-Mediated Immune Surveillance of Lymphoid Malignancies

Srividya Swaminathan, PhD, Line Dam Heftdal, MS, Daniel F Liefwalker, PhD, Renumathy Dhanasekaran, MD, Anja Deutzmann, PhD, Crista Horton, BS, Adriane Mosley, BS, Mariola Liebersbach, BS, Holden T. Maecker, PhD, Dean Felsher, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2619.
https://doi.org/10.1182/blood-2018-99-110472
Published: 2018
Journal Articles

A Proinflammatory Invariant Natural Killer T Cells Phenotypic State Associates with Human Graft-Versus-Host Disease Onset and Response

Tom Erkers, PhD, Bryan Xei, BS, Laura Kenyon, Mary Rieck, BS, Marina Basina, MD, Kent Jensen, PhD, Samuel Strober, MD, Robert S. Negrin, MD, Holden T. Maecker, PhD, Everett H Meyer, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2111.
https://doi.org/10.1182/blood-2018-99-120358
Published: 2018
Journal Articles

Durable Responses with Pembrolizumab in Relapsed/Refractory Mycosis Fungoides and Sézary Syndrome: Final Results from a Phase 2 Multicenter Study

Michael S Khodadoust, MD PhD, Alain Rook, MD, Pierluigi Porcu, MD, Francine M. Foss, MD, Alison J. Moskowitz, MD, Andrei R. Shustov, MD, Satish Shanbhag, MD, Lubomir Sokol, MD PhD, Steven P Fling, PhD, Shufeng Li, MS, Asa Davis, PhD, Sophia Fong, BS, Jinah Kim, MD PhD, Yi Yang, Jennifer H Yearley, PhD DVM, Priyanka B Subrahmanyam, PhD, Holden T. Maecker, PhD, Yelena Budovskaya, PhD, Biswajit Das, PhD, Rajesh Patidar, PhD, Vivekananda Datta, MD PhD, Chris Karlovich, PhD, Steven M. Horwitz, MD, Elad Sharon, MD MPH, Holbrook Kohrt, MD PhD, Martin A Cheever, MD, Youn H. Kim, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2896.
https://doi.org/10.1182/blood-2018-99-117244
Published: 2018
Journal Articles

Increased Incidence of Autoimmune and Infectious Diseases Among a Large Group of Diffuse Large B-Cell Lymphoma (DLBCL) Survivors: A Population-Based Study

Tanaya Shree, MD PhD, Qian Li, MS, Sally L. Glaser, PhD, Holden T. Maecker, PhD, Robert W. Haile, PhD MPH, Ronald Levy, MD, Theresa H.M. Keegan, PhD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 198.
https://doi.org/10.1182/blood.V130.Suppl_1.198.198
Published: 2017
Journal Articles

Altered Peripheral Immune Phenotypes in Mantle Cell Lymphoma Survivors

Tanaya Shree, MD PhD, Sangeeta Kowli, PhD, Holden T. Maecker, PhD, Ronald Levy, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2759.
https://doi.org/10.1182/blood.V130.Suppl_1.2759.2759
Published: 2017
Journal Articles

Disturbed NK Cell Compartment in CML Patients with Anti-Leukemia Immune Responses Under Treatment with Imatinib Mesylate

Christiane I Chen, Holden T Maecker, Rhoda Falkow, Peter P. Lee, MD
Journal: Blood
Blood (2008) 112 (11): 3202.
https://doi.org/10.1182/blood.V112.11.3202.3202
Published: 2008
Journal Articles

Development and dynamics of robust T-cell responses to CML under imatinib treatment

Christiane I-U. Chen, Holden T. Maecker, Peter P. Lee
Journal: Blood
Blood (2008) 111 (11): 5342–5349.
https://doi.org/10.1182/blood-2007-12-128397
Published: 2008
Includes: Supplemental data
Journal Articles

Robust Anti-Leukemia CD4+ and CD8+ T Cell Responses in CML Patients Treated with Imatinib Mesylate.

Christiane I.-U. Chen, MD, Alexandre Johannsen, M.S., Wesley Witteles, M.D., Holden T. Maecker, Ph.D., Peter P. Lee, M.D.
Journal: Blood
Blood (2006) 108 (11): 2199.
https://doi.org/10.1182/blood.V108.11.2199.2199
Published: 2006
Journal Articles

Anti-Leukemia Immune Responses in CML Patients Treated with Imatinib Mesylate.

Christiane I.-U. Chen, MD, Holden T. Maecker, PhD, Wesley H. Neal, MD, Rhoda Falkow, BS, Peter P. Lee, MD
Journal: Blood
Blood (2005) 106 (11): 1108.
https://doi.org/10.1182/blood.V106.11.1108.1108
Published: 2005